Sanofi SA (SNY)
47.96
+0.18
(+0.38%)
USD |
NASDAQ |
Nov 21, 15:56
Sanofi Price: 47.96 for Nov. 21, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 20, 2024 | 47.95 | 48.03 | 47.61 | 47.78 | 1.261M |
| Nov 19, 2024 | 47.98 | 48.21 | 47.84 | 48.00 | 3.337M |
| Nov 18, 2024 | 47.99 | 48.67 | 47.94 | 48.51 | 2.614M |
| Nov 15, 2024 | 47.88 | 48.18 | 47.46 | 47.97 | 3.651M |
| Nov 14, 2024 | 49.60 | 50.09 | 47.57 | 47.82 | 2.973M |
| Nov 13, 2024 | 49.81 | 49.83 | 49.21 | 49.51 | 1.681M |
| Nov 12, 2024 | 50.43 | 50.45 | 50.08 | 50.14 | 2.710M |
| Nov 11, 2024 | 51.08 | 51.17 | 50.55 | 50.62 | 2.059M |
| Nov 08, 2024 | 51.52 | 51.62 | 51.18 | 51.32 | 1.284M |
| Nov 07, 2024 | 51.48 | 51.78 | 51.37 | 51.73 | 1.389M |
| Nov 06, 2024 | 51.47 | 51.74 | 50.84 | 51.26 | 3.013M |
| Nov 05, 2024 | 52.53 | 52.91 | 52.39 | 52.85 | 851812.0 |
| Nov 04, 2024 | 53.54 | 53.56 | 52.80 | 52.95 | 1.273M |
| Nov 01, 2024 | 53.77 | 53.77 | 53.10 | 53.27 | 1.382M |
| Oct 31, 2024 | 52.92 | 53.01 | 52.40 | 52.88 | 1.396M |
| Oct 30, 2024 | 53.32 | 53.72 | 53.30 | 53.45 | 2.609M |
| Oct 29, 2024 | 54.53 | 54.59 | 53.67 | 53.83 | 1.934M |
| Oct 28, 2024 | 54.18 | 54.66 | 53.99 | 54.36 | 3.462M |
| Oct 25, 2024 | 53.90 | 54.44 | 53.42 | 54.34 | 3.252M |
| Oct 24, 2024 | 53.22 | 53.23 | 50.00 | 52.05 | 3.306M |
| Oct 23, 2024 | 53.18 | 53.41 | 52.89 | 52.89 | 2.381M |
| Oct 22, 2024 | 53.05 | 53.70 | 52.98 | 53.26 | 1.699M |
| Oct 21, 2024 | 54.55 | 54.65 | 53.51 | 53.66 | 2.240M |
| Oct 18, 2024 | 54.57 | 55.04 | 54.33 | 54.93 | 1.197M |
| Oct 17, 2024 | 54.56 | 55.02 | 54.38 | 54.86 | 1.051M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
37.22
Minimum
Sep 27 2022
58.53
Maximum
Sep 04 2024
49.88
Average
50.19
Median
Dec 17 2019
Price Benchmarks
| AstraZeneca PLC | 64.30 |
| GSK PLC | 33.70 |
| Eli Lilly and Co | 749.28 |
| Novavax Inc | 8.065 |
| Regeneron Pharmaceuticals Inc | 745.10 |
Price Related Metrics
| PE Ratio | 24.30 |
| PS Ratio | 2.264 |
| Price to Book Value | 1.543 |
| Earnings Yield | 4.11% |
| Market Cap | 120.24B |
| Operating PE Ratio | 10.46 |
| Normalized PE Ratio | 14.97 |